Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028

Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028



The pharmacogenomics market is projected to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6% during the forecast period. The growth of this market can be attributed to the research and development efforts aimed at drug discovery and development, and growing focus on personalized medicines.

“The kits & reagents segment accounted for the largest share by product & service in 2022.”

In 2022, the kits & reagents segment accounted for the largest share of product type in the global pharmacogenomics market. The factors such as growing demand for high quality reagents for genomics studies, increasing focus on development of personalized medicines, and growing number of research projects in the field of genomics are driving the growth of this market.

““The Asia Pacific region is growing in the pharmacogenomics market during the forecast period of 2023-2028.”

The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. Various factors including growing adoption of advanced sequencing technologies and booming healthcare sector are propelling the growth of pharmacogenomics market in the region.

Increased funding and investments from pharmaceutical and biotechnology companies aimed at advancing the healthcare sector are expected to propel the growth of the pharmacogenomics market in the Asia Pacific region. According to R&D Magazine, Asia has become the world's foremost region in research and development (R&D) investment, claiming over 44% of the global R&D share. The region is steadily gaining an additional half-percent share each year, and if this trend persists, it could represent more than half of all R&D investments by 2030. China is actively enhancing its R&D infrastructure and human resources capabilities, maintaining a consistent commitment to spending, ambition, and long-term planning. These factors are expected to contribute for the highest CAGR of the regionbetween 2023 to 2028.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%

By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%

By Region: North America -30%, Europe -20%, Asia-Pacific -30%, Latin America -15% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Illumina, Inc. (US)

Thermo Fisher Scientific Inc. (US)

Danaher Corporation (US)

Laboratory Corporation of America Holdings (US)

Charles River Laboratories (US)

Eurofins Scientific (Luxembourg)

Bio-Rad Laboratories, Inc. (US)

Agilent Technologies, Inc. (US)

BD (US)

QIAGEN (Netherlands)

F. Hoffmann-La Roche Ltd. (Switzerland)

Revvity (US), IQVIA Inc. (US)

Mesa Labs, Inc. (US)

Medpace (US)

MGI Tech Co., Ltd. (China)

Takara Bio Inc. (Japan)

PacBio (US)

New England Biolabs (US)

BGI (China), Novogene Co., Ltd. (China)

SOPHiA GENETICS (Switzerland), Fios Genomics (UK)

Personalis, Inc. (US)

BioAI Health Inc. (US)

NeoGenomics Laboratories (US)

Macrogen, Inc. (South Korea).)

Research Coverage:

This research report categorizes the pharmacogenomics market by product & service (kits & reagents ( sequencing kits and reagents, PCR kits and reagents, microarray kits and reagents, and other kits & reagents) and service), technology (sequencing, PCR, microarray, and other technologies), disease area (cancer, cardiovascular, neurological diseases, and other disease areas), application (personalized medicine, clinical research, and drug discovery & preclinical development), and end user (academic & research institutes, pharmaeutical & biotechechnology companies, and contract research organization)

The report provides in-depth information on significant factors influencing the growth of the pharmacogenomics market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products/services, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches, mergers, and acquisitions within the pharmacogenomics market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmacogenomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (growing incidence and prevalence of chronic and genetic diseases and rising investments and funding to support genomic projects), restraints (challenges in data integration and interpretation, and issues related to drug response variability), opportunities (growing usage of genomics in specialized/personalized medicine), and challenges (ethical & regulatory issues, concern related to patient privacy & data accessibility) influencing the growth of the market.

Product & Service Development/Innovation: Detailed insights on newly launched products/services of the pharmacogenomics market

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the pharmacogenomics market

Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Laboratory Corporation of America Holdings (US), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories, Inc. (US), Agilent Technologies, Inc. (US), BD (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), IQVIA Inc. (US), Mesa Labs, Inc. (US), Medpace (US), MGI Tech Co., Ltd. (China), Takara Bio Inc. (Japan), PacBio (US), New England Biolabs (US), among others in the market.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS AND EXCLUSIONS OF STUDY
      • MARKET SEGMENTATION
      • YEARS CONSIDERED
    • CURRENCY
    • STAKEHOLDERS
    • LIMITATIONS
    • RECESSION IMPACT
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • GROWTH FORECAST
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • RISK ANALYSIS
    • RECESSION IMPACT ANALYSIS
      • Table GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
      • Table US: HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
      • Table US: HEALTH EXPENDITURE, 2023-2030 (USD MILLION)
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PHARMACOGENOMICS MARKET OVERVIEW
    • NORTH AMERICA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
    • PHARMACOGENOMICS MARKET SHARE, BY TECHNOLOGY, 2022
    • PHARMACOGENOMICS MARKET SHARE, BY APPLICATION, 2022
    • PHARMACOGENOMICS MARKET SHARE, BY DISEASE AREA, 2022
    • PHARMACOGENOMICS MARKET SHARE, BY END USER, 2022
    • PHARMACOGENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • Table PHARMACOGENOMICS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
      • DRIVERS
        • Table CANCER INCIDENCE, 2020 VS. 2040
        • Table CANCER PGX-RELATED PHARMACOGENES, DRUG PATHWAYS, AND CANCER DRUGS WITH SIDE EFFECTS
        • Table COLLABORATIONS AND PARTNERSHIPS BETWEEN KEY PLAYERS AND RESEARCH INSTITUTES
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • TECHNOLOGY ANALYSIS
      • SEQUENCING
        • Table COMPARISON OF SANGER SEQUENCING AND NGS
      • PCR
        • Table COMPARISON OF PCR TECHNOLOGIES
      • MICROARRAY
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • REGULATORY LANDSCAPE
      • REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • REGULATORY SCENARIO
        • Table PHARMACOGENOMICS MARKET: REGULATORY SCENARIO
    • ECOSYSTEM ANALYSIS
      • PHARMACOGENOMICS PRODUCT VENDORS
        • Table PHARMACOGENOMICS PRODUCT VENDORS: ROLE IN ECOSYSTEM
      • PHARMACOGENOMICS SERVICE VENDORS
        • Table PHARMACOGENOMICS SERVICE VENDORS: ROLE IN ECOSYSTEM
      • PHARMACOGENOMICS END USERS
        • Table PHARMACOGENOMICS END USERS: ROLE IN ECOSYSTEM
      • PHARMACOGENOMICS REGULATORY BODIES
        • Table PHARMACOGENOMICS REGULATORY BODIES: ROLE IN ECOSYSTEM
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • PRICING ANALYSIS
      • AVERAGE SELLING PRICE OF PHARMACOGENOMICS PRODUCTS, BY KEY PLAYER
        • Table AVERAGE SELLING PRICE OF PHARMACOGENOMICS PRODUCTS, BY KEY PLAYER (2022)
      • AVERAGE SELLING PRICE OF PHARMACOGENOMICS PRODUCTS, BY REGION
        • Table AVERAGE SELLING PRICE OF PHARMACOGENOMICS PRODUCTS, BY REGION (2022)
      • AVERAGE SELLING PRICE TREND ANALYSIS
    • KEY CONFERENCES AND EVENTS IN 2023-2024
      • Table PHARMACOGENOMICS MARKET: LIST OF CONFERENCES AND EVENTS
    • PORTER'S FIVE FORCES ANALYSIS
      • Table PHARMACOGENOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • PATENT ANALYSIS
      • Table INDICATIVE LIST OF PATENTS IN PHARMACOGENOMICS MARKET
    • KEY STAKEHOLDERS AND BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PHARMACOGENOMICS PRODUCTS AND SERVICES
      • BUYING CRITERIA FOR PHARMACOGENOMICS MARKET
        • Table BUYING CRITERIA FOR PHARMACOGENOMICS PRODUCTS AND SERVICES, BY END USER
  • PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • KITS & REAGENTS
      • Table PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table PHARMACOGENOMICS KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • SEQUENCING KITS & REAGENTS
        • Table SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • PCR KITS & REAGENTS
        • Table PCR KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PCR KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PCR KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PCR KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PCR KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PCR KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PCR KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • MICROARRAY KITS & REAGENTS
        • Table MICROARRAY KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: MICROARRAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: MICROARRAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: MICROARRAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: MICROARRAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MICROARRAY KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: MICROARRAY KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • OTHER KITS & REAGENTS
        • Table OTHER KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: OTHER KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: OTHER KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • SERVICES
      • SCALABILITY OF CRO SERVICES ALLOWS TAILORED SOLUTIONS
        • Table PHARMACOGENOMICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • PHARMACOGENOMICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • SEQUENCING
      • GROWING ADOPTION OF GENETIC TESTING FOR DIAGNOSIS AND TREATMENT TO DRIVE MARKET
        • Table SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • PCR
      • INCREASED USE OF PCR FOR DRUG AND BIOMARKER DISCOVERY TO PROPEL MARKET
        • Table PCR MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PCR MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PCR MARKET, BY REGION, 2021-2028 (USD MILLION)
    • MICROARRAY
      • MICROARRAY HELPS UNDERSTAND GENETIC BASIS OF DRUG METABOLISM
        • Table MICROARRAY MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: MICROARRAY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: MICROARRAY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: MICROARRAY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: MICROARRAY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MICROARRAY MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: MICROARRAY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table OTHER TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: OTHER TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • PHARMACOGENOMICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • PERSONALIZED MEDICINE
      • INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
        • Table PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2021-2028 (USD MILLION)
    • CLINICAL RESEARCH
      • GROWING NUMBER OF CLINICAL TRIALS FOR PHARMACOGENOMICS TO DRIVE MARKET
        • Table PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR CLINICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • DRUG DISCOVERY & PRECLINICAL DEVELOPMENT
      • INCREASING APPLICATIONS OF PHARMACOGENOMICS IN DRUG DISCOVERY AND DEVELOPMENT TO SUPPORT MARKET GROWTH
        • Table PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR DRUG DISCOVERY & PRECLINICAL DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
  • PHARMACOGENOMICS MARKET, BY DISEASE AREA
    • INTRODUCTION
      • Table PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
    • CANCER
      • INCREASING PREVALENCE OF CANCER TO DRIVE MARKET
        • Table PHARMACOGENOMICS MARKET FOR CANCER, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR CANCER, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR CANCER, BY REGION, 2021-2028 (USD MILLION)
    • CARDIOVASCULAR DISEASE
      • RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
        • Table PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2021-2028 (USD MILLION)
    • NEUROLOGICAL DISORDERS
      • GROWING DEMAND FOR PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
        • Table PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER DISEASE AREAS
      • Table PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY REGION, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR OTHER DISEASE AREAS, BY REGION, 2021-2028 (USD MILLION)
  • PHARMACOGENOMICS MARKET, BY END USER
    • INTRODUCTION
      • Table PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • INCREASING RESEARCH ACTIVITIES AND FUNDING TO DRIVE GROWTH
        • Table PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • GROWING STRATEGIC ALLIANCES FOR DRUG DEVELOPMENT AND PERSONALIZED MEDICINE TO PROPEL MARKET
        • Table PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • INCREASING OUTSOURCING TREND IN GENOMICS FIELD TO PROPEL MARKET
        • Table PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
  • PHARMACOGENOMICS MARKET, BY REGION
    • INTRODUCTION
      • Table PHARMACOGENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • US
        • Table US: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table US: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table US: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table US: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table US: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table CANADA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table CANADA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CANADA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table CANADA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • RECESSION IMPACT ON NORTH AMERICAN PHARMACOGENOMICS MARKET
    • EUROPE
      • Table EUROPE: PHARMACOGENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
      • Table EUROPE: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table GERMANY: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table GERMANY: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GERMANY: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table GERMANY: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • UK
        • Table UK: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table UK: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table UK: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table UK: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table UK: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table FRANCE: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table FRANCE: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table FRANCE: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table FRANCE: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table ITALY: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table ITALY: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ITALY: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table ITALY: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table SPAIN: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table SPAIN: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SPAIN: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table SPAIN: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021- 2028 (USD MILLION)
        • Table REST OF EUROPE: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • RECESSION IMPACT ON EUROPEAN PHARMACOGENOMICS MARKET
    • ASIA PACIFIC
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table CHINA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table CHINA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CHINA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table CHINA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table JAPAN: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table JAPAN: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table JAPAN: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table JAPAN: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table INDIA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table INDIA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table INDIA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table INDIA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • RECESSION IMPACT ON ASIA PACIFIC PHARMACOGENOMICS MARKET
    • LATIN AMERICA
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table BRAZIL: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table BRAZIL: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table BRAZIL: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table BRAZIL: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • MEXICO
        • Table MEXICO: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table MEXICO: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table MEXICO: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table MEXICO: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table MEXICO: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021- 2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • RECESSION IMPACT ON LATIN AMERICAN PHARMACOGENOMICS MARKET
    • MIDDLE EAST & AFRICA
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • MIDDLE EAST
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • AFRICA
        • Table AFRICA: PHARMACOGENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table AFRICA: PHARMACOGENOMICS KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table AFRICA: PHARMACOGENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table AFRICA: PHARMACOGENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table AFRICA: PHARMACOGENOMICS MARKET, BY DISEASE AREA, 2021-2028 (USD MILLION)
        • Table AFRICA: PHARMACOGENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • RECESSION IMPACT ON MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • STRATEGIES ADOPTED BY KEY PLAYERS
    • REVENUE SHARE ANALYSIS
    • MARKET SHARE ANALYSIS
      • Table PHARMACOGENOMICS MARKET: INTENSITY OF COMPETITIVE RIVALRY
    • COMPANY EVALUATION MATRIX
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
      • COMPANY FOOTPRINT
        • Table PRODUCT & SERVICE FOOTPRINT
        • Table REGIONAL FOOTPRINT
    • STARTUP/SME EVALUATION MATRIX
      • PROGRESSIVE COMPANIES
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
      • STARTING BLOCKS
    • COMPETITIVE BENCHMARKING
      • Table PHARMACOGENOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
      • Table PHARMACOGENOMICS MARKET: PRODUCT & SERVICE AND REGIONAL FOOTPRINT OF KEY STARTUPS/SMES
    • COMPETITIVE SCENARIO
      • Table PHARMACOGENOMICS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020-DECEMBER 2023
      • Table PHARMACOGENOMICS MARKET: DEALS, JANUARY 2020-DECEMBER 2023
      • Table PHARMACOGENOMICS MARKET: OTHER DEVELOPMENTS, JANUARY 2020- DECEMBER 2023
  • COMPANY PROFILES
    • KEY PLAYERS
      • ILLUMINA, INC.
        • Table ILLUMINA, INC.: BUSINESS OVERVIEW
      • THERMO FISHER SCIENTIFIC INC.
        • Table THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
      • F. HOFFMANN-LA ROCHE LTD.
        • Table F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
      • QIAGEN
        • Table QIAGEN: BUSINESS OVERVIEW
      • DANAHER CORPORATION
        • Table DANAHER CORPORATION: BUSINESS OVERVIEW
      • LABORATORY CORPORATION OF AMERICA HOLDINGS
        • Table LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
      • EUROFINS SCIENTIFIC
        • Table EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
      • CHARLES RIVER LABORATORIES
        • Table CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
      • BIO-RAD LABORATORIES, INC.
        • Table BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
      • AGILENT TECHNOLOGIES, INC.
        • Table AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
      • BECTON, DICKINSON AND COMPANY
        • Table BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
      • REVVITY
        • Table REVVITY: BUSINESS OVERVIEW
      • IQVIA, INC.
        • Table IQVIA, INC.: BUSINESS OVERVIEW
      • MESA LABS, INC.
        • Table MESA LABORATORIES, INC.: BUSINESS OVERVIEW
      • MEDPACE, INC.
        • Table MEDPACE, INC.: BUSINESS OVERVIEW
      • MGI TECH CO., LTD.
        • Table MGI TECH CO., LTD.: BUSINESS OVERVIEW
    • OTHER PLAYERS
      • PACBIO
        • Table PACBIO: COMPANY OVERVIEW
      • TAKARA BIO INC.
        • Table TAKARA BIO INC.: COMPANY OVERVIEW
      • NEW ENGLAND BIOLABS
        • Table NEW ENGLAND BIOLABS: COMPANY OVERVIEW
      • BGI
        • Table BGI: COMPANY OVERVIEW
      • NOVOGENE CO., LTD.
        • Table NOVOGENE CO., LTD.: COMPANY OVERVIEW
      • SOPHIA GENETICS
        • Table SOPHIA GENETICS: COMPANY OVERVIEW
      • FIOS GENOMICS
        • Table FIOS GENOMICS: COMPANY OVERVIEW
      • PERSONALIS, INC.
        • Table PERSONALIS, INC.: COMPANY OVERVIEW
      • NEOGENOMICS LABORATORIES
        • Table NEOGENOMICS LABORATORIES: COMPANY OVERVIEW
      • BIOAI HEALTH INC.
        • Table BIOAI HEALTH INC.: COMPANY OVERVIEW
      • MACROGEN, INC.
        • Table MACROGEN, INC.: COMPANY OVERVIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings